|
2025
|
Invention
|
Lambda n-based compositions and methods for nucleic acids editing. The present disclosure provide... |
|
|
Invention
|
Rna-editing oligonucleotides and uses thereof.
The present disclosure features useful compositio... |
|
2024
|
Invention
|
Double-stranded rna-editing oligonucleotides and uses thereof. The present invention relates to m... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of genetic diseases; Pharmaceutical products for ce... |
|
|
Invention
|
Oligonucleotides comprising phosphoramidate internucleotide linkages. Provided herein are oligonu... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of rare genetic diseases; Pharmaceutical preparatio... |
|
|
G/S
|
Oligonucleotide preparations for the treatment of genetic diseases Custom manufacture of biomedic... |
|
|
G/S
|
Oligonucleotide preparations for the treatment of genetic diseases. Custom manufacture of biomedi... |
|
|
Invention
|
Rna-editing oligonucleotides and uses thereof. The present disclosure features useful composition... |
|
|
G/S
|
Oligonucleotide compounds being a component in pharmaceutical preparations for the treatment of g... |
|
|
Invention
|
Oligonucleotides for rna editing. e.ge.g., a polynucleotide comprising a SNP associated with a di... |
|
|
G/S
|
Oligonucleotide preparations for the treatment of genetic diseases Pharmaceutical research and de... |
|
2023
|
Invention
|
Compositions and methods for nucleic acid editing. The present disclosure provides, in part, comp... |
|
2022
|
Invention
|
Methods and compositions for the adar-mediated editing of leucine rich repeat kinase 2 (lrrk2).
... |
|
|
Invention
|
Methods and compositions for the adar-mediated editing of argininosuccinate lyase (asl).
The pre... |
|
|
Invention
|
Methods and compositions for the adar-mediated editing of methyl-cpg binding protein 2 (mecp2).
... |
|
|
Invention
|
Methods and compositions for the adar-mediated editing of transmembrane channel-like protein 1 (t... |
|
|
Invention
|
Methods and compositions for the adar-mediated editing of gap junction protein beta 2 (gjb2).
Th... |
|
|
Invention
|
Methods and compositions for the adar-mediated editing of retinochisin 1 (rs1).
The present inve... |
|
|
Invention
|
Methods and compositions for the adar-mediated editing of argininosuccinate synthetase (ass1).
T... |
|
|
Invention
|
Methods and compositions for the adar-mediated editing of otoferlin (otof).
The present inventio... |
|
|
Invention
|
Methods and compositions for disrupting nrf2-keap1 protein interaction by adar mediated rna editi... |
|
|
G/S
|
Custom manufacture of biomedical compounds comprised of nucleotide polymers or biomedical compoun... |
|
|
G/S
|
Pharmaceutical research and development; Pharmaceutical research and development in the fields of... |
|
|
Invention
|
Methods and compositions for adar-mediated editing.
The present invention relates to methods and... |
|
|
Invention
|
Methods and compositions for adar-mediated editing. e.g.,e.g., a polynucleotide comprising a SNP ... |
|
|
Invention
|
Methods for restoring protein function using adar. The present invention relates to methods and c... |
|
|
Invention
|
Rna-editing enzyme-recruiting oligonucleotides and uses thereof.
The present disclosure features... |
|
2021
|
Invention
|
Methods and compositions for the adar-mediated editing of serpina1.
The present invention relate... |
|
|
Invention
|
Methods and compositions for the adar-mediated editing of serpina1. e.g.,e.g., a SERPINA1 polynuc... |
|
|
Invention
|
Methods and compositions for the adar-mediated editing of abca4.
The present invention relates t... |
|
|
Invention
|
Methods and compositions for the adar-mediated editing of abca4. e.g.,e.g., an ABCA4 polynucleoti... |
|
|
Invention
|
Methods and compositions for the adar-mediated editing of leucine rich repeat kinase 2 (lrrk2). e... |
|
|
Invention
|
Methods and compositions for the adar-mediated editing of otoferlin (otof). e.g.e.g., an OTOF pol... |
|
|
Invention
|
Methods and compositions for the adar-mediated editing of argininosuccinate lyase (asl). The pres... |
|
|
Invention
|
Methods and compositions for the adar-mediated editing of argininosuccinate synthetase (ass1). Th... |
|
|
Invention
|
Methods and compositions for the adar-mediated editing of gap junction protein beta 2 (gjb2). The... |
|
|
Invention
|
Methods and compositions for the adar-mediated editing of methyl-cpg binding protein 2 (mecp2). T... |
|
|
Invention
|
Methods and compositions for the adar-mediated editing of retinoschisin 1 (rs1). The present inve... |
|
|
G/S
|
Oligonucleotide compounds being a component in
pharmaceutical preparations for the treatment of ... |
|
2020
|
G/S
|
Research and development of pharmaceutical products; research and development in the field of bio... |
|
2019
|
G/S
|
Pharmaceutical preparations for the treatment of rare genetic diseases. Pharmaceutical research a... |
